Hamideh Shahheydari
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Amyotrophic Lateral Sclerosis Research, Synthesis and biological activity, Cutaneous Melanoma Detection and Management, Neurogenetic and Muscular Disorders Research
Most-Cited Works
- → Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma(2014)381 cited
- → Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations(2020)115 cited
- → The Formin INF2 Regulates Basolateral-to-Apical Transcytosis and Lumen Formation in Association with Cdc42 and MAL2(2010)98 cited
- → CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis(2020)85 cited
- → Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients(2014)70 cited
- → Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum(2017)59 cited
- → Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy(2017)50 cited
- → Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress(2019)40 cited
- → The Redox Activity of Protein Disulfide Isomerase Inhibits ALS Phenotypes in Cellular and Zebrafish Models(2020)37 cited
- → Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF (cyclin F) complex(2017)30 cited